Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
162M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
132M
-
Shares change
-
+18M
-
Total reported value, excl. options
-
$1.62B
-
Value change
-
+$223M
-
Put/Call ratio
-
0.67
-
Number of buys
-
78
-
Number of sells
-
-45
-
Price
-
$12.32
Significant Holders of IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) as of Q1 2014
157 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK as of Q1 2014.
IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 132M shares
of 162M outstanding shares and own 81.48% of the company stock.
Largest 10 shareholders include FMR LLC (19.8M shares), WELLINGTON MANAGEMENT CO LLP (16.6M shares), BVF INC/IL (9.3M shares), MORGAN STANLEY (8.13M shares), VANGUARD GROUP INC (7.15M shares), DEUTSCHE BANK AG\ (6.36M shares), STATE OF WISCONSIN INVESTMENT BOARD (6.3M shares), JANUS CAPITAL MANAGEMENT LLC (5.95M shares), MILLENNIUM MANAGEMENT LLC (5.31M shares), and BlackRock Fund Advisors (4.96M shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.